Ke-Vin Chang Selected Research

Ke-Vin Chang Research Topics

Disease

23	Pain (Aches) 11/2023 - 07/2012
12	Shoulder Pain 12/2022 - 11/2015
9	Stroke (Strokes) 01/2023 - 10/2015
7	Sarcopenia 11/2023 - 01/2017
5	Tendinopathy (Tendonitis) 01/2024 - 10/2015
5	Bursitis (Adhesive Capsulitis) 01/2023 - 09/2016
4	Carpal Tunnel Syndrome 01/2022 - 03/2020
3	Fibromyalgia (Fibrositis) 01/2023 - 01/2022
3	Myalgia 01/2023 - 01/2022
3	Osteoarthritis 10/2022 - 05/2013
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2024 - 01/2015
2	Tennis Elbow (Elbow, Tennis) 03/2024 - 02/2018
2	Neoplasms (Cancer) 11/2023 - 11/2015
2	Hyperalgesia 01/2023 - 01/2022
2	De Quervain Disease 01/2023 - 01/2017
2	Knee Osteoarthritis 11/2022 - 01/2020
2	Arthritis (Polyarthritis) 11/2022 - 11/2020
2	Wounds and Injuries (Trauma) 07/2022 - 09/2012
2	Chronic Pain 01/2022 - 11/2020
2	Deglutition Disorders (Dysphagia) 11/2021 - 01/2021
2	Musculoskeletal Pain 12/2020 - 11/2020
2	Shock 09/2015 - 07/2012
2	Plantar Fasciitis 09/2015 - 07/2012
1	Radial Neuropathy (Saturday Night Palsy) 12/2023
1	Rheumatoid Arthritis 12/2023
1	Scoliosis 07/2023
1	Rupture 03/2023
1	Neuralgia (Stump Neuralgia) 01/2023
1	Inflammation (Inflammations) 01/2023
1	Muscular Atrophy (Muscle Atrophy) 10/2022
1	Necrosis 07/2022
1	Blindness (Hysterical Blindness) 07/2022
1	Inguinal Hernia (Direct Inguinal Hernia) 07/2022
1	Rectal Neoplasms (Rectal Cancer) 06/2022
1	Lymphatic Metastasis 06/2022
1	Cauda Equina Syndrome 02/2022
1	Hypersensitivity (Allergy) 01/2022
1	Fistula 01/2022

Drug/Important Bio-Agent (IBA)

14	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2023 - 09/2015
5	Glucose (Dextrose)FDA LinkGeneric 07/2023 - 01/2016
5	Botulinum Toxins (Botulinum Toxin)IBA 01/2022 - 02/2018
4	Lidocaine (Xylocaine)FDA LinkGeneric 07/2023 - 12/2020
4	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 01/2023 - 01/2021
3	CalciumIBA 11/2023 - 12/2020
3	Analgesics (Analgesic Drugs)IBA 01/2023 - 11/2015
2	Branched-Chain Amino AcidsIBA 11/2023 - 12/2020
2	Cholecalciferol (Vitamin D3)FDA Link 11/2023 - 12/2020
2	CytokinesIBA 01/2023 - 11/2020
2	Substance PIBA 01/2023 - 01/2022
2	Hyaluronic Acid (Hyaluronan)IBA 11/2022 - 05/2013
2	salicylhydroxamic acid (SHAM)IBA 06/2022 - 11/2020
2	AntioxidantsIBA 01/2022 - 11/2021
2	mesoglycanIBA 11/2020 - 11/2020
1	Taurine FDA Link 05/2024
1	Capsules (Microcapsules)IBA 12/2023
1	InterleukinsIBA 11/2023
1	Interleukin-15 (Interleukin 15)IBA 11/2023
1	Interleukin-6 (Interleukin 6)IBA 11/2023
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2023
1	Saline SolutionIBA 07/2023
1	Opioid Analgesics (Opioids)IBA 01/2023
1	Nerve Growth Factors (Neurotrophins)IBA 01/2023
1	Diclofenac (SR 38)FDA LinkGeneric 01/2023
1	Ibuprofen (Motrin)FDA LinkGeneric 01/2023
1	4-O-carboxymethylascochlorinIBA 01/2023
1	Ion Channels (Ion Channel)IBA 01/2023
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2023
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2023
1	Deep-HeatIBA 12/2022
1	Immune Checkpoint InhibitorsIBA 10/2022
1	PolydeoxyribonucleotidesIBA 10/2022
1	AcidsIBA 01/2022
1	coenzyme Q10 (CoQ10)IBA 01/2022
1	Acid Sensing Ion ChannelsIBA 01/2022

Therapy/Procedure

16	Injections 01/2024 - 01/2016
8	Therapeutics 12/2022 - 07/2012
5	Ultrasonic Therapy 01/2023 - 09/2012
5	Nerve Block (Nerve Blocks) 01/2021 - 11/2015
4	Extracorporeal Shockwave Therapy 01/2022 - 07/2012
3	Conservative Treatment 01/2023 - 08/2021
3	Prolotherapy 01/2022 - 10/2015
2	Duration of Therapy 11/2023 - 01/2022
2	Analgesia 01/2023 - 01/2022
2	Resistance Training 01/2023 - 01/2021
2	Intra-Articular Injections 11/2022 - 01/2016
2	Subacute Care 08/2022 - 01/2022
2	Prostheses and Implants (Prosthesis) 01/2022 - 02/2013
2	Nutritional Support (Artificial Feeding) 01/2021 - 01/2020
1	Splints (Splint) 03/2024
1	Transcranial Magnetic Stimulation 01/2023
1	Enteral Nutrition (Feeding, Tube) 01/2023
1	Diathermy 12/2022
1	Viscosupplementation 11/2022
1	Transjugular Intrahepatic Portasystemic Shunt 07/2022
1	Drug Therapy (Chemotherapy) 06/2022
1	Decompression 02/2022
1	Laminectomy 02/2022
1	Phalloplasty 01/2022
1	Length of Stay 01/2022
1	Reoperation 01/2022